A systematic review investigating the role of hormonal treatment in nonmetastatic prostate cancer recurrence concluded that for most patients hormonal treatment may be more harmful than beneficial, as only patients with aggressive prostate cancer and a rapidly rising prostate-specific antigen might benefit from early hormonal treatment (22). Here, KLK3 is linked to prostate cancer.